HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tadashi Yoshino Selected Research

Submandibular Gland Diseases

8/2014T helper 2 and regulatory T-cell cytokine production by mast cells: a key factor in the pathogenesis of IgG4-related disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tadashi Yoshino Research Topics

Disease

56Neoplasms (Cancer)
12/2022 - 04/2002
53Lymphoma (Lymphomas)
10/2022 - 02/2002
27Immunoglobulin G4-Related Disease
12/2020 - 12/2009
27Marginal Zone B-Cell Lymphoma (MALT Lymphoma)
09/2020 - 04/2002
18Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
10/2022 - 12/2003
18Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2022 - 12/2003
17B-Cell Lymphoma (Lymphoma, B Cell)
09/2019 - 05/2003
15Inflammation (Inflammations)
10/2019 - 09/2002
14Lymphadenopathy
12/2019 - 06/2008
12Multi-centric Castleman's Disease
10/2019 - 01/2004
11Lymphoproliferative Disorders (Lymphoproliferative Disorder)
09/2022 - 05/2003
10Infections
10/2019 - 08/2005
10Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
11/2017 - 12/2003
8T-Cell Lymphoma (Lymphoma, T Cell)
09/2022 - 06/2003
7Anemia
03/2020 - 11/2005
7Carcinoma (Carcinomatosis)
04/2017 - 07/2010
7Lung Neoplasms (Lung Cancer)
01/2017 - 03/2002
6Hodgkin Disease (Hodgkin's Disease)
01/2022 - 11/2011
6Fibrosis (Cirrhosis)
10/2019 - 01/2013
6Thrombocytopenia (Thrombopenia)
10/2019 - 11/2005
6Autoimmune Diseases (Autoimmune Disease)
01/2019 - 04/2002
6Leukemia
11/2017 - 11/2002
6Sepsis (Septicemia)
07/2016 - 02/2003
5Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated)
11/2020 - 02/2002
5Castleman Disease (Castleman's Disease)
03/2020 - 12/2012
5Carcinogenesis
11/2019 - 09/2008
5Edema (Dropsy)
10/2019 - 01/2013
5Rheumatoid Arthritis
01/2018 - 01/2012
5Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
12/2017 - 06/2003
5Adenocarcinoma
10/2013 - 03/2002
4Spontaneous Remission
01/2022 - 06/2017
4Fever (Fevers)
10/2019 - 01/2013
4Hypergammaglobulinemia (Hyperimmunoglobulinemia)
01/2019 - 06/2008
4Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
01/2019 - 04/2010
4Hypoalbuminemia
11/2017 - 01/2012
3Ulcer
11/2021 - 09/2005
3Diabetes Complications
01/2020 - 03/2010
3Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous)
10/2015 - 08/2002
3Langerhans-Cell Histiocytosis (Histiocytosis, Langerhans Cell)
02/2015 - 08/2011
3Pathologic Complete Response
01/2015 - 01/2008
3Non-Hodgkin Lymphoma (Lymphosarcoma)
09/2014 - 02/2002
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
03/2008 - 03/2002

Drug/Important Bio-Agent (IBA)

26Immunoglobulin G (IgG)IBA
04/2021 - 01/2004
18Proteins (Proteins, Gene)FDA Link
12/2022 - 11/2002
15Rituximab (Mabthera)FDA Link
02/2021 - 01/2008
13ParaffinIBA
04/2020 - 01/2003
12Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA
09/2021 - 09/2004
12Immunoglobulins (Immunoglobulin)IBA
01/2019 - 04/2002
11Interleukin-6 (Interleukin 6)IBA
12/2020 - 02/2002
10Methotrexate (Mexate)FDA LinkGeneric
09/2022 - 05/2009
10AntigensIBA
12/2018 - 11/2003
9CytokinesIBA
06/2022 - 01/2004
9InterleukinsIBA
03/2020 - 11/2005
7Interleukin-2 Receptors (IL 2 Receptor)IBA
11/2021 - 07/2009
7Doxorubicin (Adriamycin)FDA LinkGeneric
01/2021 - 06/2005
7Prednisone (Sone)FDA LinkGeneric
01/2021 - 06/2005
7Vincristine (Oncovin)FDA LinkGeneric
01/2021 - 06/2005
7Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2021 - 06/2005
7Cyclin D1IBA
11/2017 - 01/2008
7Interleukin-18 (Interleukin 18)IBA
08/2006 - 09/2002
6Immunoglobulin A (IgA)IBA
12/2020 - 04/2002
6DNA (Deoxyribonucleic Acid)IBA
12/2020 - 09/2009
6C-Reactive ProteinIBA
03/2020 - 04/2009
6Formaldehyde (Formol)FDA Link
03/2018 - 05/2003
6Immunoglobulin E (IgE)IBA
01/2018 - 01/2004
6HMGB1 Protein (HMG1)IBA
01/2017 - 12/2007
5SteroidsIBA
03/2019 - 11/2005
5T-Cell Antigen Receptors (T-Cell Receptor)IBA
12/2018 - 04/2009
5Immunoglobulin M (IgM)IBA
06/2017 - 04/2002
5Monoclonal AntibodiesIBA
01/2017 - 12/2007
5LipopolysaccharidesIBA
04/2016 - 02/2003
5Messenger RNA (mRNA)IBA
08/2015 - 11/2002
4Advanced Glycation End ProductsIBA
11/2021 - 03/2010
4glycolaldehydeIBA
11/2021 - 09/2009
4Cytidine DeaminaseIBA
04/2021 - 07/2009
4Indicators and Reagents (Reagents)IBA
04/2020 - 01/2014
4Biomarkers (Surrogate Marker)IBA
03/2020 - 01/2010
4Reticulin (Reticular Fiber)IBA
10/2019 - 01/2013
4Interleukin-1 (Interleukin 1)IBA
01/2018 - 01/2015
4AntibodiesIBA
01/2018 - 06/2004
4Anaplastic Lymphoma KinaseIBA
12/2017 - 06/2003
4ErbB Receptors (EGF Receptor)IBA
01/2017 - 09/2008
3LigandsIBA
01/2022 - 01/2019
3GlyceraldehydeIBA
01/2020 - 09/2009
3Immunoglobulin Light Chains (Immunoglobulin Light Chain)IBA
03/2019 - 01/2012
3Etoposide (VP 16)FDA LinkGeneric
12/2017 - 09/2002
3Interleukin-4 (Interleukin 4)IBA
12/2015 - 01/2004
3RNA (Ribonucleic Acid)IBA
10/2015 - 11/2008
3Biological ProductsIBA
09/2013 - 10/2005
3Adrenal Cortex Hormones (Corticosteroids)IBA
01/2013 - 04/2002
3Cyclin-Dependent Kinase Inhibitor p16IBA
06/2008 - 12/2004
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2006 - 02/2002

Therapy/Procedure

34Therapeutics
07/2022 - 08/2002
22Drug Therapy (Chemotherapy)
07/2022 - 03/2002
12Radiotherapy
10/2022 - 06/2005
5Chemoradiotherapy
11/2014 - 12/2003
4Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation)
12/2003 - 04/2002
3Gastrectomy
04/2018 - 06/2005
3Ligation
07/2016 - 03/2010
3Transplantation
04/2008 - 04/2002